|
Volumn 83, Issue 2, 2001, Pages 121-136
|
Classical swine fever (CSF) marker vaccine: Trial III. Evaluation of discriminatory ELISAs
|
Author keywords
Classical swine fever virus; Discriminatory ELISA; Marker vaccine; Pig viruses; Sensitivity; Specificity
|
Indexed keywords
BAYOVAC;
GLYCOPROTEIN E;
NEUTRALIZING ANTIBODY;
PORCILIS PESTI;
VIRUS VACCINE;
ANIMAL EXPERIMENT;
ANTIBODY TITER;
ARTICLE;
CONTROLLED STUDY;
DIAGNOSTIC ACCURACY;
ENZYME LINKED IMMUNOSORBENT ASSAY;
EVALUATION;
INTERMETHOD COMPARISON;
LABORATORY;
LICENSING;
NONHUMAN;
PESTIVIRUS;
RELIABILITY;
SERODIAGNOSIS;
SERUM;
SWINE DISEASE;
VACCINE PRODUCTION;
VALIDATION PROCESS;
VIRUS CHARACTERIZATION;
VIRUS DETECTION;
WEANING;
ANIMALS;
ANTIBODIES, VIRAL;
CLASSICAL SWINE FEVER;
CLASSICAL SWINE FEVER VIRUS;
ENZYME-LINKED IMMUNOSORBENT ASSAY;
EUROPEAN UNION;
REPRODUCIBILITY OF RESULTS;
SENSITIVITY AND SPECIFICITY;
SWINE;
VACCINES, MARKER;
VIRAL VACCINES;
BOVINE VIRAL DIARRHEA VIRUS 1;
CLASSICAL SWINE FEVER VIRUS;
SUS SCROFA;
|
EID: 0035829399
PISSN: 03781135
EISSN: None
Source Type: Journal
DOI: 10.1016/S0378-1135(01)00411-4 Document Type: Article |
Times cited : (62)
|
References (48)
|